F. nucleatum promotes an immunosuppressive milieu by interacting with both tumor cells and immune cells, hindering the effectiveness of immunotherapies such as checkpoint inhibitors (e.g., PD-1/PD-L1 inhibitors), CAR T-cell therapies, and other immune modulators [96,97,98,99,100]. This evidence concerns the gene CD274 and neoplasm.